Cost‐Effectiveness of Screening for Unhealthy Alcohol Use with %Carbohydrate Deficient Transferrin: Results From a Literature‐Based Decision Analytic Computer Model
Authors:
- Alok KapoorAKAlok Kapoor
- Kevin L. KraemerKKKevin L. Kraemer
- Kenneth J. SmithKSKenneth J. Smith
- Mark S. RobertsMRMark S. Roberts
- Richard SaitzRSRichard Saitz
- 27 July 2009
- journal article
- research article
- Published by Wiley in Alcohol, Clinical and Experimental Research
- Vol. 33 (8) , 1440-1449
Abstract
Background: The %carbohydrate deficient transferrin (%CDT) test offers objective evidence of unhealthy alcohol use but its cost‐effectiveness in primary care conditions is unknown. Methods: Using a decision tree and Markov model, we performed a literature‐based cost‐effectiveness analysis of 4 strategies for detecting unhealthy alcohol use in adult primary care patients: (i) Questionnaire Only, using a validated 3‐item alcohol questionnaire; (ii) %CDT Only; (iii) Questionnaire followed by %CDT (Questionnaire‐%CDT) if the questionnaire is negative; and (iv) No Screening. For those patients screening positive, clinicians performed more detailed assessment to characterize unhealthy use and determine therapy. We estimated costs using Medicare reimbursement and the Medical Expenditure Panel Survey. We determined sensitivity, specificity, prevalence of disease, and mortality from the medical literature. In the base case, we calculated the incremental cost‐effectiveness ratio (ICER) in 2006 dollars per quality‐adjusted life year ($/QALY) for a 50‐year‐old cohort. Results: In the base case, the ICER for the Questionnaire‐%CDT strategy was $15,500/QALY compared with the Questionnaire Only strategy. Other strategies were dominated. When the prevalence of unhealthy alcohol use exceeded 15% and screening age was <60 years, the Questionnaire‐%CDT strategy costs less than $50,000/QALY compared to the Questionnaire Only strategy. Conclusions: Adding %CDT to questionnaire‐based screening for unhealthy alcohol use was cost‐effective in our literature‐based decision analytic model set in typical primary care conditions. Screening with %CDT should be considered for adults up to the age of 60 when the prevalence of unhealthy alcohol use is 15% or more and screening questionnaires are negative.Keywords
This publication has 40 references indexed in Scilit:
- DOVER and QUVER—New Marker Combinations to Detect and Monitor At‐risk DrinkingAlcohol, Clinical and Experimental Research, 2006
- Bias in published cost effectiveness studies: systematic reviewBMJ, 2006
- Opportunistic screening for alcohol use disorders in primary care: comparative studyBMJ, 2006
- Alcohol Biomarker Screening in Medical and Surgical SettingsAlcohol, Clinical and Experimental Research, 2006
- Five-Year Clinical Course Associated With DSM-IV Alcohol Abuse or Dependence in a Large Group of Men and WomenAmerican Journal of Psychiatry, 2001
- Alcohol Consumption, Alcohol Dependence, and All‐Cause MortalityAlcohol, Clinical and Experimental Research, 2000
- Toward Consistency in Cost-Utility AnalysesMedical Care, 1998
- Tobacco, Alcohol, and Drug Use in a Primary Care SampleJournal of Addictive Diseases, 1998
- Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and MedicineJAMA, 1996
- The utilization of medical care by treated alcoholics: Longitudinal patterns by age, gender, and type of careJournal of Substance Abuse, 1991